Welcome to Paid Research Studies


Browse Locations ... United States» ... Massachusetts» ... Cambridge





  • Condition:   Periodontal Disease
    Interventions:   Biological: ST266;   Drug: Saline (0.9% NaCl)
    Sponsor:   Noveome Biotherapeutics, formerly Stemnion
    Recruiting - verified April 2016

  • Conditions:   Urinary Incontinence;   Urinary Bladder, Overactive;   Lower Urinary Tract Symptoms
    Intervention:   Other: Preprocedure Telephone Call
    Sponsor:   Boston Urogynecology Associates
    Not yet recruiting - verified April 2016

  • Condition:   Urinary Incontinence, Stress
    Intervention:   Other: Informational Handout
    Sponsor:   Boston Urogynecology Associates
    Recruiting - verified April 2016

  • Conditions:   Breast Neoplasms;   Breast Diseases;   Neoplasms;   Neoplasms by Site;   Fulvestrant;   Antineoplastic Agents;   Antineoplastic Agents, Hormonal;   Estrogen Receptor Antagonists;   Hormone Antagonists;   Hormones, Hormone Substitutes, and Hormone Antagonists;   Molecular Mechanisms of Pharmacological Action;   Pharmacologic Actions;   Therapeutic Use
    Interventions:   Drug: Ribociclib;   Drug: fulvestrant;   Drug: Ribociclib placebo
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified April 2016

  • Condition:   Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
    Intervention:  
    Sponsors:   Genentech, Inc.;   Accord Healthcare, Inc.;   Sandoz Inc.;   Apotex Corporation;   Novartis Pharmaceuticals;   Pfizer;   Mylan Pharmaceuticals;   Teva Pharmaceuticals USA;   Alkem Laboratories Ltd;   Roxane Laboratories;   Vintage Pharmaceuticals, LLC
    Recruiting - verified May 2016

  • Condition:   Diabetic Foot Infection
    Interventions:   Drug: Topical pexiganan cream 0.8%;   Drug: Topical placebo cream;   Other: Standard wound care
    Sponsor:   Dipexium Pharmaceuticals, Inc.
    Recruiting - verified April 2016

  • Conditions:   Non-Small Cell Lung Cancer;   Anemia;   Cancer;   Lung Cancer
    Interventions:   Drug: darbepoetin alfa 500 mcg Q3W;   Drug: placebo
    Sponsor:   Amgen
    Recruiting - verified April 2016

  • Conditions:   Glycogen Storage Disease Type II (GSD-II);   Pompe Disease (Late-onset);   Glycogenesis 2 Acid Maltase Deficiency
    Interventions:   Biological: alglucosidase alpha;   Other: No Treatment
    Sponsor:   Genzyme, a Sanofi Company
    Recruiting - verified April 2016